Genetics of lipoprotein disorders

Area of Science:

• Lipoprotein metabolism
• Cellular physiology
• Molecular genetics
• Protein chemistry

Background:

• Advances in lipoprotein metabolism research have significantly improved medical diagnostics and therapeutics.
• Early identification of patients at high risk for atherosclerosis enables timely intervention with lipid-lowering therapy.
• Familial dyslipoproteinemia is a common factor in premature cardiovascular disease (CAD).

Purpose of the Study:

• To review the genetics of atherogenic lipoprotein disorders.
• To highlight the importance of identifying genetic defects in dyslipidemias.
• To emphasize multifactorial etiologies and gene-environment interactions in atherogenic risk.

Main Methods:

• Review of genetic factors in atherogenic lipoprotein disorders.
• Analysis of multifactorial etiologies and risk factor clustering.
• Consideration of gene-gene and gene-environment interactions.

Main Results:

• Identification of major genetic defects is crucial for managing atherogenic lipoprotein disorders.
• Multifactorial etiologies and risk factor interactions significantly influence atherogenic potential.
• Table 2 provides a summary of diagnosis, clinical implications, and treatment for inherited dyslipidemias.

Conclusions:

• Genetics plays a key role in atherogenic lipoprotein disorders, necessitating identification of defects.
• Comprehensive assessment requires considering genetic, multifactorial, and environmental influences.
• Effective management strategies for dyslipidemias involve early diagnosis and tailored therapies.